ÂÜÀòÂÒÂ×

Stuart Gibson is Chief Financial Officer of Microbiotica. He is an experienced finance executive with over 25 years’ experience at Board level, managing financial teams, fundraising, M&A and commercial transactions in VC – and Private Equity-backed life sciences and technology companies.

Stuart played a key role in the growth of Arakis from 2001 through to its sale in 2006 to the Japanese pharma company Sosei. Following the sale he was appointed to the Board of Sosei and raised further funding on the Tokyo stock market. His experience includes contract negotiations with customers and business partners globally including North Africa, Middle East and China.

Stuart is a qualified chartered accountant and is a guest lecturer on finance on several MPhil Biosciences courses at Cambridge University. In addition to his role at Microbiotica, Stuart works with small portfolio of early-stage life sciences providing financial and corporate management support.